181 related articles for article (PubMed ID: 7587928)
1. The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig.
Witkamp RF; Nijmeijer SM; Monshouwer M; Van Miert AS
Drug Metab Dispos; 1995 May; 23(5):542-7. PubMed ID: 7587928
[TBL] [Abstract][Full Text] [Related]
2. In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle.
Zweers-Zeilmaker WM; Van Miert AS; Horbach GJ; Witkamp RF
Res Vet Sci; 1999 Feb; 66(1):51-5. PubMed ID: 10088712
[TBL] [Abstract][Full Text] [Related]
3. Tiamulin selectively inhibits oxidative hepatic steroid and drug metabolism in vitro in the pig.
Witkamp RF; Nijmeijer SM; Csikó G; van Miert AS
J Vet Pharmacol Ther; 1994 Aug; 17(4):317-22. PubMed ID: 7966553
[TBL] [Abstract][Full Text] [Related]
4. Biochemical background of toxic interaction between tiamulin and monensin.
Szucs G; Tamási V; Laczay P; Monostory K
Chem Biol Interact; 2004 Mar; 147(2):151-61. PubMed ID: 15013817
[TBL] [Abstract][Full Text] [Related]
5. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
Kasahara M; Suzuki H; Komiya I
Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P-450 complex formation in rat liver by the antibiotic tiamulin.
Witkamp RF; Nijmeijer SM; van Miert AS
Antimicrob Agents Chemother; 1996 Jan; 40(1):50-4. PubMed ID: 8787878
[TBL] [Abstract][Full Text] [Related]
7. In vitro formation of metabolic-intermediate cytochrome P450 complexes in rabbit liver microsomes by tiamulin and various macrolides.
Carletti M; Gusson F; Zaghini A; Dacasto M; Marvasi L; Nebbia C
Vet Res; 2003; 34(4):405-11. PubMed ID: 12911857
[TBL] [Abstract][Full Text] [Related]
8. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
Nebbia C; Ceppa L; Dacasto M; Carletti M; Nachtmann C
Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804
[TBL] [Abstract][Full Text] [Related]
9. Inhibition and induction of cytochrome P450 isozymes after repetitive administration of imipramine in rats.
Masubuchi Y; Takahashii C; Fujio N; Horie T; Suzuki T; Imaoka S; Funae Y; Narimatsu S
Drug Metab Dispos; 1995 Sep; 23(9):999-1003. PubMed ID: 8565792
[TBL] [Abstract][Full Text] [Related]
10. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
Yu L; Waxman DJ
Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
[TBL] [Abstract][Full Text] [Related]
11. Enhanced rates of cytochrome P450 metabolic-intermediate complex formation from nonmacrolide amines in rifampicin-treated rabbit liver microsomes.
Franklin MR
Drug Metab Dispos; 1995 Dec; 23(12):1379-82. PubMed ID: 8689947
[TBL] [Abstract][Full Text] [Related]
12. Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver.
Arinç E; Bozcaarmutlu A
J Biochem Mol Toxicol; 2003; 17(3):169-76. PubMed ID: 12815613
[TBL] [Abstract][Full Text] [Related]
13. Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes.
Poet TS; McQueen CA; Halpert JR
Drug Metab Dispos; 1996 Jan; 24(1):74-80. PubMed ID: 8825193
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines.
Chang TK; Yu L; Maurel P; Waxman DJ
Cancer Res; 1997 May; 57(10):1946-54. PubMed ID: 9157990
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
Grubb MF; Diamond S; Christ DD
Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
[TBL] [Abstract][Full Text] [Related]
17. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs.
Li J; Liu Y; Zhang JW; Wei H; Yang L
Comp Med; 2006 Aug; 56(4):286-90. PubMed ID: 16941956
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
Pichard L; Fabre I; Fabre G; Domergue J; Saint Aubert B; Mourad G; Maurel P
Drug Metab Dispos; 1990; 18(5):595-606. PubMed ID: 1981707
[TBL] [Abstract][Full Text] [Related]
19. Hepatic cytochrome P450 induction in goats. Effects of model inducers on the metabolism of alkoxyresorufins, testosterone and ethylmorphine, and on apoprotein and mRNA levels.
van't Klooster GA; Horbach GJ; Natsuhori M; Blaauboer BJ; Noordhoek J; van Miert AS
Biochem Pharmacol; 1993 Jan; 45(1):113-22. PubMed ID: 8424805
[TBL] [Abstract][Full Text] [Related]
20. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
